Indications and limitations of afamelanotide for treating vitiligo

JAMA Dermatol. 2015 Mar;151(3):349-50. doi: 10.1001/jamadermatol.2014.4848.
No abstract available

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Ultraviolet Therapy / methods*
  • Vitiligo / therapy*
  • alpha-MSH / analogs & derivatives*

Substances

  • alpha-MSH